Literature DB >> 768477

Genetics of the complement system.

P Lachmann.   

Abstract

The complement system, unlike the coagulation system, was largely characterized by in-vitro techniques which did not make use of genetically deficient plasmas. The existence of the genetically deficient plasmas. The existence of the genetically deficient subjects therefore has served largely to increase our knowledge of the in-vivo role of complement. At the present time its clearest role is in the resistance to infection; obviously in the case of C3 deficiency and bacterial infection and possibly more subtly in the case of deficiency of the early active complement components and low virulence organisms. There is so far no evidence that genetic complement deficiency interferes with antibody formation or with the generation of tolerance as has been suggested in the pas (Azar et al, 1968; Dukor and Hartmann, 1973).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 768477      PMCID: PMC1013316          DOI: 10.1136/jmg.12.4.372

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  33 in total

1.  [ESSENTIAL HYPOCOMPLEMENTEMIA].

Authors:  A HAESSIG; J F BOREL; P AMMANN; M THOENI; R BUETLER
Journal:  Pathol Microbiol (Basel)       Date:  1964

2.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

3.  Hypothesis. Bound C3 as the second signal for B-cell activation.

Authors:  P Dukor; K U Hartmann
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

4.  Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus.

Authors:  V Agnello; M M De Bracco; H G Kunkel
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

Review 5.  Hereditary angio-oedema: a review with particular reference to pathogenesis and treatment.

Authors:  K Hadjiyannaki; P J Lachmann
Journal:  Clin Allergy       Date:  1971-06

6.  Studies of an additional kindred with hereditary deficiency of the second component of human complement (C2) and description of a new method for the quantitation of C2.

Authors:  N R Cooper; R ten Bensel; P F Kohler
Journal:  J Immunol       Date:  1968-12       Impact factor: 5.422

7.  Hereditary deficiency of the second component of complement (C'2) in man: further observations on a second kindred.

Authors:  M R Klemperer; K F Austen; F S Rosen
Journal:  J Immunol       Date:  1967-01       Impact factor: 5.422

8.  Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies.

Authors:  J P Leddy; M M Frank; T Gaither; J Baum; M R Klemperer
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

9.  Karyotypic, virologic, and immunologic analyses of two continuous lymphocyte lines established from New Zealand black mice: possible relationship of chromosomal mosaicism to autoimmunity.

Authors:  R A Lerner; F Jensen; S J Kennel; F J Dixon; G Des Roches; U Francke
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

10.  Genetic polymorphism in human glycine-rich beta-glycoprotein.

Authors:  C A Alper; T Boenisch; L Watson
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more
  1 in total

1.  Sca-1 influences the innate immune response during skeletal muscle regeneration.

Authors:  Kimberly K Long; Grace K Pavlath; Monty Montano
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.